chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Myalgia, Pyrexia
Clinical narrative: fever; chills; joint pain; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007M20A and 042L20A) for COVID-19 vaccination.     Family history included Migraine since an unknown date.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient experienced PYREXIA (fever), CHILLS (chills), ARTHRALGIA (joint pain) and MYALGIA (muscle pain). The patient was treated with ACETAMINOPHEN for Migraine, at an unspecified dose and frequency. At the time of the report, PYREXIA (fever), CHILLS (chills), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) outcome was unknown.            No concomitant medication were provided  Action taken with mRNA-1273 Moderna vaccine was Not applicable
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: Extremely sore arm on injection site; tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Extremely sore arm on injection site) and FATIGUE (tired) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No medical reported history provided by the reporter.  Concomitant products included AZITHROMYCIN (Z-PAK) and FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (Extremely sore arm on injection site) and FATIGUE (tired). On 12-Feb-2021, FATIGUE (tired) had resolved. On 13-Feb-2021, VACCINATION SITE PAIN (Extremely sore arm on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication details was reported.   This case was linked to MOD-2021-073429 (Patient Link).
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Healthcare provider calling because a patient received her 2nd dose to early; the 2nd dose was given within 17 day and not at 28 days.; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Healthcare provider calling because a patient received her 2nd dose to early; the 2nd dose was given within 17 day and not at 28 days.) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047M21A and 047M21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Healthcare provider calling because a patient received her 2nd dose to early; the 2nd dose was given within 17 day and not at 28 days.). On 08-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Healthcare provider calling because a patient received her 2nd dose to early; the 2nd dose was given within 17 day and not at 28 days.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment medications were reported.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Fatigue, Feeling abnormal, Hyperhidrosis
Clinical narrative: felt as if "tons of bricks hit her"; irritable; sweating; hands clammy; feel tired; chills on and off; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy) and FATIGUE (feel tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off). At the time of the report, FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy) and FATIGUE (feel tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off). At the time of the report, FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported.  No treatment information was provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Irritability
Clinical narrative: felt as if "tons of bricks hit her"; irritable; sweating; hands clammy; feel tired; chills on and off; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy) and FATIGUE (feel tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off). At the time of the report, FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy) and FATIGUE (feel tired) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off). At the time of the report, FEELING ABNORMAL (felt as if "tons of bricks hit her"), IRRITABILITY (irritable), HYPERHIDROSIS (sweating), COLD SWEAT (hands clammy), FATIGUE (feel tired) and CHILLS (chills on and off) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported.  No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Lymph node pain
Clinical narrative: Skin raised with blister like bumps by nose; Very acidy nasal drip/area was sore for a couple of days; Sore area by nose; Small scab by; I got a cold it lasted two days; Lymph nodes achy; Painful swelling by nose; Fatigue; Fever of 101 F; Headache/excrutiating headache between her eyes; Muscle aches after 2nd dose/Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Painful swelling by nose), RASH VESICULAR (Skin raised with blister like bumps by nose), NASAL INFLAMMATION (Very acidy nasal drip/area was sore for a couple of days), NASAL DISCOMFORT (Sore area by nose) and SCAB (Small scab by ) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer (right side 10 years ago.).   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced FATIGUE (Fatigue), PYREXIA (Fever of 101 F), HEADACHE (Headache/excrutiating headache between her eyes), MYALGIA (Muscle aches after 2nd dose/Body aches) and CHILLS (Chills). On 04-Apr-2021, the patient experienced SWELLING FACE (Painful swelling by nose). On an unknown date, the patient experienced RASH VESICULAR (Skin raised with blister like bumps by nose), NASAL INFLAMMATION (Very acidy nasal drip/area was sore for a couple of days), NASAL DISCOMFORT (Sore area by nose), SCAB (Small scab by ), NASOPHARYNGITIS (I got a cold it lasted two days) and LYMPH NODE PAIN (Lymph nodes achy). At the time of the report, SWELLING FACE (Painful swelling by nose), RASH VESICULAR (Skin raised with blister like bumps by nose), NASAL INFLAMMATION (Very acidy nasal drip/area was sore for a couple of days), SCAB (Small scab by ), LYMPH NODE PAIN (Lymph nodes achy), FATIGUE (Fatigue), PYREXIA (Fever of 101 F), HEADACHE (Headache/excrutiating headache between her eyes), MYALGIA (Muscle aches after 2nd dose/Body aches) and CHILLS (Chills) outcome was unknown, NASAL DISCOMFORT (Sore area by nose) was resolving and NASOPHARYNGITIS (I got a cold it lasted two days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Body temperature: 101 (abnormal) Fever of 101 F.         Concomitant product use was not provided by the reporter.   ?No treatment information was provided.   This case was linked to MOD-2021-073362 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: New event Cold was added. On 21-Jul-2021: Non-Significant Follow Up Appended
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nasal discomfort, Nasal inflammation, Nasopharyngitis, Pyrexia
Clinical narrative: Skin raised with blister like bumps by nose; Very acidy nasal drip/area was sore for a couple of days; Sore area by nose; Small scab by; I got a cold it lasted two days; Lymph nodes achy; Painful swelling by nose; Fatigue; Fever of 101 F; Headache/excrutiating headache between her eyes; Muscle aches after 2nd dose/Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Painful swelling by nose), RASH VESICULAR (Skin raised with blister like bumps by nose), NASAL INFLAMMATION (Very acidy nasal drip/area was sore for a couple of days), NASAL DISCOMFORT (Sore area by nose) and SCAB (Small scab by ) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer (right side 10 years ago.).   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced FATIGUE (Fatigue), PYREXIA (Fever of 101 F), HEADACHE (Headache/excrutiating headache between her eyes), MYALGIA (Muscle aches after 2nd dose/Body aches) and CHILLS (Chills). On 04-Apr-2021, the patient experienced SWELLING FACE (Painful swelling by nose). On an unknown date, the patient experienced RASH VESICULAR (Skin raised with blister like bumps by nose), NASAL INFLAMMATION (Very acidy nasal drip/area was sore for a couple of days), NASAL DISCOMFORT (Sore area by nose), SCAB (Small scab by ), NASOPHARYNGITIS (I got a cold it lasted two days) and LYMPH NODE PAIN (Lymph nodes achy). At the time of the report, SWELLING FACE (Painful swelling by nose), RASH VESICULAR (Skin raised with blister like bumps by nose), NASAL INFLAMMATION (Very acidy nasal drip/area was sore for a couple of days), SCAB (Small scab by ), LYMPH NODE PAIN (Lymph nodes achy), FATIGUE (Fatigue), PYREXIA (Fever of 101 F), HEADACHE (Headache/excrutiating headache between her eyes), MYALGIA (Muscle aches after 2nd dose/Body aches) and CHILLS (Chills) outcome was unknown, NASAL DISCOMFORT (Sore area by nose) was resolving and NASOPHARYNGITIS (I got a cold it lasted two days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Body temperature: 101 (abnormal) Fever of 101 F.         Concomitant product use was not provided by the reporter.   ?No treatment information was provided.   This case was linked to MOD-2021-073362 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: New event Cold was added. On 21-Jul-2021: Non-Significant Follow Up Appended
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rash vesicular, Scab, Swelling face
Clinical narrative: Skin raised with blister like bumps by nose; Very acidy nasal drip/area was sore for a couple of days; Sore area by nose; Small scab by; I got a cold it lasted two days; Lymph nodes achy; Painful swelling by nose; Fatigue; Fever of 101 F; Headache/excrutiating headache between her eyes; Muscle aches after 2nd dose/Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Painful swelling by nose), RASH VESICULAR (Skin raised with blister like bumps by nose), NASAL INFLAMMATION (Very acidy nasal drip/area was sore for a couple of days), NASAL DISCOMFORT (Sore area by nose) and SCAB (Small scab by ) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer (right side 10 years ago.).   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced FATIGUE (Fatigue), PYREXIA (Fever of 101 F), HEADACHE (Headache/excrutiating headache between her eyes), MYALGIA (Muscle aches after 2nd dose/Body aches) and CHILLS (Chills). On 04-Apr-2021, the patient experienced SWELLING FACE (Painful swelling by nose). On an unknown date, the patient experienced RASH VESICULAR (Skin raised with blister like bumps by nose), NASAL INFLAMMATION (Very acidy nasal drip/area was sore for a couple of days), NASAL DISCOMFORT (Sore area by nose), SCAB (Small scab by ), NASOPHARYNGITIS (I got a cold it lasted two days) and LYMPH NODE PAIN (Lymph nodes achy). At the time of the report, SWELLING FACE (Painful swelling by nose), RASH VESICULAR (Skin raised with blister like bumps by nose), NASAL INFLAMMATION (Very acidy nasal drip/area was sore for a couple of days), SCAB (Small scab by ), LYMPH NODE PAIN (Lymph nodes achy), FATIGUE (Fatigue), PYREXIA (Fever of 101 F), HEADACHE (Headache/excrutiating headache between her eyes), MYALGIA (Muscle aches after 2nd dose/Body aches) and CHILLS (Chills) outcome was unknown, NASAL DISCOMFORT (Sore area by nose) was resolving and NASOPHARYNGITIS (I got a cold it lasted two days) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Apr-2021, Body temperature: 101 (abnormal) Fever of 101 F.         Concomitant product use was not provided by the reporter.   ?No treatment information was provided.   This case was linked to MOD-2021-073362 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: New event Cold was added. On 21-Jul-2021: Non-Significant Follow Up Appended
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: tiredness; headaches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness) and HEADACHE (headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced FATIGUE (tiredness) and HEADACHE (headaches). At the time of the report, FATIGUE (tiredness) and HEADACHE (headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Tinnitus
Clinical narrative: worsening tinnitus; headache; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (worsening tinnitus) and HEADACHE (headache) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced TINNITUS (worsening tinnitus) and HEADACHE (headache). At the time of the report, TINNITUS (worsening tinnitus) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment medications were not reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Myalgia, Pyrexia
Clinical narrative: muscle pain; fever; chills; brain fog; massive headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (brain fog), MYALGIA (muscle pain), PYREXIA (fever), CHILLS (chills) and HEADACHE (massive headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 07M20A) for COVID-19 vaccination.     Family history included Migraine.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (massive headache). On 21-Feb-2021, the patient experienced FEELING ABNORMAL (brain fog). On an unknown date, the patient experienced MYALGIA (muscle pain), PYREXIA (fever) and CHILLS (chills). The patient was treated with ACETAMINOPHEN for Headache, at a dose of 325 mg twice a day. At the time of the report, FEELING ABNORMAL (brain fog), MYALGIA (muscle pain), PYREXIA (fever) and CHILLS (chills) outcome was unknown and HEADACHE (massive headache) had not resolved.            Action taken with mRNA-1273 in response to the event was not applicable. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to MOD-2021-073383 (Patient Link).
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient passed the recommend time frame for second dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient passed the recommend time frame for second dose) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient passed the recommend time frame for second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient passed the recommend time frame for second dose) had resolved.            Duration between first shot and second shot: typing error: 35 days instead of 41 days  Concomitant product use was not provided.  Treatment information was unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Brenner tumour
Clinical narrative: BrEN; This spontaneous case was reported by an other health care professional and describes the occurrence of BRENNER TUMOUR (BrEN) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced BRENNER TUMOUR (BrEN). At the time of the report, BRENNER TUMOUR (BrEN) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   NO CONCOMINANT,TREATMENT MEDICATIONS WERE USED. LAB DATA WAS NOT GIVEN   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: No specific follow-up information recorded.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided.  No treatment information was provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Tinnitus
Clinical narrative: "ringing noise in his brain"; not able to sleep; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 10-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS ("ringing noise in his brain") and INSOMNIA (not able to sleep) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 027A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced TINNITUS ("ringing noise in his brain") and INSOMNIA (not able to sleep). At the time of the report, TINNITUS ("ringing noise in his brain") and INSOMNIA (not able to sleep) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Neck pain, Nuchal rigidity, Pyrexia
Clinical narrative: Pain necking that is getting worse; Cant move due to the strong pain neck; Excreting a lot of pee; Injection site is very sore; Nausea; Fever; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 10-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain necking that is getting worse), NUCHAL RIGIDITY (Cant move due to the strong pain neck), URINE OUTPUT INCREASED (Excreting a lot of pee), VACCINATION SITE PAIN (Injection site is very sore) and NAUSEA (Nausea) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced URINE OUTPUT INCREASED (Excreting a lot of pee), VACCINATION SITE PAIN (Injection site is very sore), NAUSEA (Nausea), PYREXIA (Fever) and HEADACHE (Headache). On 09-Apr-2021, the patient experienced NECK PAIN (Pain necking that is getting worse) and NUCHAL RIGIDITY (Cant move due to the strong pain neck). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, NECK PAIN (Pain necking that is getting worse), NUCHAL RIGIDITY (Cant move due to the strong pain neck), URINE OUTPUT INCREASED (Excreting a lot of pee), VACCINATION SITE PAIN (Injection site is very sore), NAUSEA (Nausea), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No  Concomitant medications were provided
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Urine output increased, Vaccination site pain
Clinical narrative: Pain necking that is getting worse; Cant move due to the strong pain neck; Excreting a lot of pee; Injection site is very sore; Nausea; Fever; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 10-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain necking that is getting worse), NUCHAL RIGIDITY (Cant move due to the strong pain neck), URINE OUTPUT INCREASED (Excreting a lot of pee), VACCINATION SITE PAIN (Injection site is very sore) and NAUSEA (Nausea) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced URINE OUTPUT INCREASED (Excreting a lot of pee), VACCINATION SITE PAIN (Injection site is very sore), NAUSEA (Nausea), PYREXIA (Fever) and HEADACHE (Headache). On 09-Apr-2021, the patient experienced NECK PAIN (Pain necking that is getting worse) and NUCHAL RIGIDITY (Cant move due to the strong pain neck). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, NECK PAIN (Pain necking that is getting worse), NUCHAL RIGIDITY (Cant move due to the strong pain neck), URINE OUTPUT INCREASED (Excreting a lot of pee), VACCINATION SITE PAIN (Injection site is very sore), NAUSEA (Nausea), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No  Concomitant medications were provided
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate abnormal, Hypoaesthesia, Hypopnoea, Paraesthesia
Clinical narrative: Shortness of breath which is still lingering; Breathing is not so good; Shallow breathing, not every breath but roughly once a minute; Heart beats a little harder than normal sometimes; Pinky finger on both hands is numb; Pins and needles all over her body; Having a lot of mucous; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath which is still lingering), DYSPNOEA (Breathing is not so good), HYPOPNOEA (Shallow breathing, not every breath but roughly once a minute), HEART RATE ABNORMAL (Heart beats a little harder than normal sometimes) and HYPOAESTHESIA (Pinky finger on both hands is numb) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included NAPROXEN SODIUM (ALEVE) for Scoliosis, ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath which is still lingering), DYSPNOEA (Breathing is not so good), HYPOPNOEA (Shallow breathing, not every breath but roughly once a minute), HEART RATE ABNORMAL (Heart beats a little harder than normal sometimes), HYPOAESTHESIA (Pinky finger on both hands is numb), PARAESTHESIA (Pins and needles all over her body) and SPUTUM ABNORMAL (Having a lot of mucous). At the time of the report, DYSPNOEA (Shortness of breath which is still lingering), DYSPNOEA (Breathing is not so good), HYPOPNOEA (Shallow breathing, not every breath but roughly once a minute), HEART RATE ABNORMAL (Heart beats a little harder than normal sometimes), HYPOAESTHESIA (Pinky finger on both hands is numb), PARAESTHESIA (Pins and needles all over her body) and SPUTUM ABNORMAL (Having a lot of mucous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment: Reported taking a baby aspirin before bed one night after experiencing pins and needles in both hands. Also took a mucous drug to help with phlegm.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Sputum abnormal
Clinical narrative: Shortness of breath which is still lingering; Breathing is not so good; Shallow breathing, not every breath but roughly once a minute; Heart beats a little harder than normal sometimes; Pinky finger on both hands is numb; Pins and needles all over her body; Having a lot of mucous; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath which is still lingering), DYSPNOEA (Breathing is not so good), HYPOPNOEA (Shallow breathing, not every breath but roughly once a minute), HEART RATE ABNORMAL (Heart beats a little harder than normal sometimes) and HYPOAESTHESIA (Pinky finger on both hands is numb) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included NAPROXEN SODIUM (ALEVE) for Scoliosis, ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath which is still lingering), DYSPNOEA (Breathing is not so good), HYPOPNOEA (Shallow breathing, not every breath but roughly once a minute), HEART RATE ABNORMAL (Heart beats a little harder than normal sometimes), HYPOAESTHESIA (Pinky finger on both hands is numb), PARAESTHESIA (Pins and needles all over her body) and SPUTUM ABNORMAL (Having a lot of mucous). At the time of the report, DYSPNOEA (Shortness of breath which is still lingering), DYSPNOEA (Breathing is not so good), HYPOPNOEA (Shallow breathing, not every breath but roughly once a minute), HEART RATE ABNORMAL (Heart beats a little harder than normal sometimes), HYPOAESTHESIA (Pinky finger on both hands is numb), PARAESTHESIA (Pins and needles all over her body) and SPUTUM ABNORMAL (Having a lot of mucous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment: Reported taking a baby aspirin before bed one night after experiencing pins and needles in both hands. Also took a mucous drug to help with phlegm.   Reporter did not allow further contact
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: little more than light soreness in the arm where he received the Moderna COVID-19 injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little more than light soreness in the arm where he received the Moderna COVID-19 injection) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced PAIN IN EXTREMITY (little more than light soreness in the arm where he received the Moderna COVID-19 injection). At the time of the report, PAIN IN EXTREMITY (little more than light soreness in the arm where he received the Moderna COVID-19 injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were provided.   This case was linked to MOD21-072534, MOD21-072518 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Constipation, Dysuria, Epistaxis, Feeling abnormal, Infection
Clinical narrative: A week after the vaccination, caller had a blood infection; experiencing urinary symptoms; still has to go to the bathroom every 5 minutes because i can not hold it even if she tried¨, this has never happened; Last week she has a nosebleed; i had never had none of this problems in my life¨; Constipation; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFECTION (A week after the vaccination, caller had a blood infection), URINARY TRACT INFECTION (experiencing urinary symptoms), DYSURIA (still has to go to the bathroom every 5 minutes because i can not hold it even if she tried¨, this has never happened), EPISTAXIS (Last week she has a nosebleed) and FEELING ABNORMAL (i had never had none of this problems in my life¨) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SALBUTAMOL (VENTOLINE [SALBUTAMOL]), TIOTROPIUM BROMIDE (SPIRIVA) and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFECTION (A week after the vaccination, caller had a blood infection), URINARY TRACT INFECTION (experiencing urinary symptoms), DYSURIA (still has to go to the bathroom every 5 minutes because i can not hold it even if she tried¨, this has never happened), EPISTAXIS (Last week she has a nosebleed), FEELING ABNORMAL (i had never had none of this problems in my life¨) and CONSTIPATION (Constipation). The patient was treated with CIPROFLOXACIN at a dose of 500 mg, 5 days; CEPHALEXIN [CEFALEXIN] at a dose of 500 mg for 5 days and PERMETHRIN at an unspecified dose and frequency. At the time of the report, INFECTION (A week after the vaccination, caller had a blood infection), URINARY TRACT INFECTION (experiencing urinary symptoms), DYSURIA (still has to go to the bathroom every 5 minutes because i can not hold it even if she tried¨, this has never happened), EPISTAXIS (Last week she has a nosebleed), FEELING ABNORMAL (i had never had none of this problems in my life¨) and CONSTIPATION (Constipation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications include blood pressure medication.   Treatment medication include Medication for constipation.   This case was linked to MOD-2021-073259, MOD-2021-073241.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: A week after the vaccination, caller had a blood infection; experiencing urinary symptoms; still has to go to the bathroom every 5 minutes because i can not hold it even if she tried¨, this has never happened; Last week she has a nosebleed; i had never had none of this problems in my life¨; Constipation; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFECTION (A week after the vaccination, caller had a blood infection), URINARY TRACT INFECTION (experiencing urinary symptoms), DYSURIA (still has to go to the bathroom every 5 minutes because i can not hold it even if she tried¨, this has never happened), EPISTAXIS (Last week she has a nosebleed) and FEELING ABNORMAL (i had never had none of this problems in my life¨) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included SALBUTAMOL (VENTOLINE [SALBUTAMOL]), TIOTROPIUM BROMIDE (SPIRIVA) and BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFECTION (A week after the vaccination, caller had a blood infection), URINARY TRACT INFECTION (experiencing urinary symptoms), DYSURIA (still has to go to the bathroom every 5 minutes because i can not hold it even if she tried¨, this has never happened), EPISTAXIS (Last week she has a nosebleed), FEELING ABNORMAL (i had never had none of this problems in my life¨) and CONSTIPATION (Constipation). The patient was treated with CIPROFLOXACIN at a dose of 500 mg, 5 days; CEPHALEXIN [CEFALEXIN] at a dose of 500 mg for 5 days and PERMETHRIN at an unspecified dose and frequency. At the time of the report, INFECTION (A week after the vaccination, caller had a blood infection), URINARY TRACT INFECTION (experiencing urinary symptoms), DYSURIA (still has to go to the bathroom every 5 minutes because i can not hold it even if she tried¨, this has never happened), EPISTAXIS (Last week she has a nosebleed), FEELING ABNORMAL (i had never had none of this problems in my life¨) and CONSTIPATION (Constipation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other concomitant medications include blood pressure medication.   Treatment medication include Medication for constipation.   This case was linked to MOD-2021-073259, MOD-2021-073241.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Gait inability, Hypoaesthesia, Myalgia, Pain in extremity
Clinical narrative: Injection site hot; Injection site itching; Tiredness; Injection site red; Muscle pain; legs started to hurt really bad; numb; could not really walk; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (legs started to hurt really bad), HYPOAESTHESIA (numb), GAIT INABILITY (could not really walk), VACCINATION SITE WARMTH (Injection site hot) and VACCINATION SITE PRURITUS (Injection site itching) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN IN EXTREMITY (legs started to hurt really bad), HYPOAESTHESIA (numb) and GAIT INABILITY (could not really walk). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itching), FATIGUE (Tiredness), VACCINATION SITE ERYTHEMA (Injection site red) and MYALGIA (Muscle pain). At the time of the report, PAIN IN EXTREMITY (legs started to hurt really bad), HYPOAESTHESIA (numb), GAIT INABILITY (could not really walk), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itching), FATIGUE (Tiredness), VACCINATION SITE ERYTHEMA (Injection site red) and MYALGIA (Muscle pain) outcome was unknown.            Treatment information not provided. List of concomitant medication were not given.    Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Additional events Injection site redness, injection site itching, fatigue, injection site hot, muscle pain added.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Injection site hot; Injection site itching; Tiredness; Injection site red; Muscle pain; legs started to hurt really bad; numb; could not really walk; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (legs started to hurt really bad), HYPOAESTHESIA (numb), GAIT INABILITY (could not really walk), VACCINATION SITE WARMTH (Injection site hot) and VACCINATION SITE PRURITUS (Injection site itching) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced PAIN IN EXTREMITY (legs started to hurt really bad), HYPOAESTHESIA (numb) and GAIT INABILITY (could not really walk). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itching), FATIGUE (Tiredness), VACCINATION SITE ERYTHEMA (Injection site red) and MYALGIA (Muscle pain). At the time of the report, PAIN IN EXTREMITY (legs started to hurt really bad), HYPOAESTHESIA (numb), GAIT INABILITY (could not really walk), VACCINATION SITE WARMTH (Injection site hot), VACCINATION SITE PRURITUS (Injection site itching), FATIGUE (Tiredness), VACCINATION SITE ERYTHEMA (Injection site red) and MYALGIA (Muscle pain) outcome was unknown.            Treatment information not provided. List of concomitant medication were not given.    Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Additional events Injection site redness, injection site itching, fatigue, injection site hot, muscle pain added.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Body temperature, Chills, Influenza A virus test, Influenza B virus test
Clinical narrative: Hip and back muscle pain; bedridden; nausea; Sore arm injection site ,could not lift arm; Swollen Throat; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swollen Throat), PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden), PYREXIA (fever) and CHILLS (chills) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PHARYNGEAL SWELLING (Swollen Throat), PYREXIA (fever), CHILLS (chills) and VACCINATION SITE PAIN (Sore arm injection site ,could not lift arm). On 07-Apr-2021, the patient experienced PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden) and NAUSEA (nausea). At the time of the report, PHARYNGEAL SWELLING (Swollen Throat), PAIN (Hip and back muscle pain), BEDRIDDEN (bedridden), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE PAIN (Sore arm injection site ,could not lift arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Apr-2021, Body temperature: 99.2 (High) 99.2. On 07-Apr-2021, Influenza A virus test: (Negative) Negative. On 07-Apr-2021, Influenza B virus test: (Negative) Negative. On 07-Apr-2021, Respiratory syncytial virus test: (Negative) Negative. On 07-Apr-2021, SARS-CoV-2 test: (Negative) Negative. On 07-Apr-2021, Streptococcus test: (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Additional information received on 20-May-2021 contains no new information.